GE Healthcare Exec Says Has Not Seen Signs Of Procedure Slowdown In Scan Data Or Contrast Agent Use; Q4 Orders Book Looks A Little Better Than It Did In Q3; More Spect Imaging Customers Are Considering Moving To Pet Imaging; China Market Is Recovering, Seeing Improvement In Activity And Tender Execution; Seeing More Volume-based Procurement Activity In China; In Current Tariff Environment Co Is In Pretty Good Shape Entering 2027
-Conference Call.
Share
Why It Matters
GE Healthcare is not seeing customers slow down their medical imaging purchases. The company thinks business will stay solid even with trade costs going up.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.